Walleye Trading’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-23,777
| Closed | -$185K | – | 4186 |
|
|
2025
Q4 | $185K | Buy |
+23,777
| New | +$172K | ﹤0.01% | 3432 |
|
|
2024
Q1 | – | Sell |
-55,761
| Closed | -$334K | – | 4805 |
|
|
2023
Q4 | $334K | Buy |
55,761
+45,805
| +460% | +$265K | 0.01% | 3408 |
|
|
2023
Q3 | $70.5K | Buy |
9,956
+9,466
| +1,932% | +$68K | ﹤0.01% | 4109 |
|
|
2023
Q2 | $3.45K | Buy |
+490
| New | +$3.93K | ﹤0.01% | 4407 |
|
|
2023
Q1 | – | Sell |
-62,105
| Closed | -$598K | – | 4929 |
|
|
2022
Q4 | $713K | Buy |
62,105
+46,016
| +286% | +$574K | 0.02% | 2534 |
|
|
2022
Q3 | $203K | Buy |
16,089
+4,669
| +41% | +$60.1K | 0.01% | 3657 |
|
|
2022
Q2 | $121K | Sell |
11,420
-7,912
| -41% | -$81.6K | ﹤0.01% | 4038 |
|
|
2022
Q1 | $314K | Sell |
19,332
-17,390
| -47% | -$279K | 0.01% | 3404 |
|
|
2021
Q4 | $509K | Sell |
36,722
-87,981
| -71% | -$1.16M | 0.01% | 2946 |
|
|
2021
Q3 | $1.79M | Buy |
124,703
+21,006
| +20% | +$331K | 0.04% | 1703 |
|
|
2021
Q2 | $1.64M | Buy |
+103,697
| New | +$1.41M | 0.04% | 1665 |
|
|
2021
Q1 | – | Sell |
-18,772
| Closed | -$140K | – | 4866 |
|
|
2020
Q4 | $140K | Buy |
+18,772
| New | +$96.8K | ﹤0.01% | 3745 |
|
|
2020
Q2 | – | Sell |
-42,086
| Closed | -$84K | – | 4289 |
|
|
2020
Q1 | $84K | Sell |
42,086
-3,000
| -7% | -$8.26K | 0.01% | 3207 |
|
|
2019
Q4 | $156K | Buy |
+45,086
| New | +$113K | 0.01% | 3332 |
|
|
2018
Q4 | – | Sell |
-1,245
| Closed | -$9K | – | 4662 |
|
|
2018
Q3 | $9K | Buy |
+1,245
| New | +$8.36K | ﹤0.01% | 5002 |
|
|
2017
Q2 | – | Sell |
-37,700
| Closed | -$317 | – | 4517 |
|
|
2017
Q1 | $317 | Buy |
+37,700
| New | +$262K | 0.01% | 2608 |
|
|
2016
Q1 | – | Sell |
-2,000
| Closed | -$21K | – | 5350 |
|
|
2015
Q4 | $21K | Sell |
2,000
-1,600
| -44% | -$15.9K | ﹤0.01% | 4389 |
|
|
2015
Q3 | $41K | Buy |
3,600
+3,100
| +620% | +$41.4K | ﹤0.01% | 3639 |
|
|
2015
Q2 | $7K | Buy |
+500
| New | +$5.68K | ﹤0.01% | 4398 |
|
Other funds holding BCRX
RCM
DM
VPM
VCM
TCM
PA
VPC